Virginia Patent of the Month – August 2025
In a groundbreaking development for infectious disease treatment, Amerimmune LLC has secured a new patent for a method to treat diseases caused by the SARS-CoV-2 RNA virus. The invention, detailed in U.S. Patent No. 12377127, titled ‘Treatment for diseases caused by RNA virus SARS-CoV-2’, focuses on a new therapeutic pathway. It moves away from directly fighting the virus. Instead, it targets a patient’s own immune response.
Treating Cell Death, Not Just Viral Load
The patent describes a method to stop a process called pyroptosis. Pyroptosis is the death of immune cells, specifically T cells. The inventors found that COVID-19 patients have high levels of an enzyme called caspase. This enzyme triggers pyroptosis. This cell death can lead to a weakened immune system. It also fuels an uncontrolled inflammatory response. Amerimmune’s method uses a caspase inhibitor. This treatment aims to reduce T cell death. It works best early in the infection. This could prevent progression to severe disease, especially in at-risk patients.
Broader Implications for High-Risk Groups
The patent claims highlight the real-world impact of this therapy. It is specifically designed for patients with pre-existing conditions. These include diabetes, heart disease, and obesity. The invention also targets immunocompromised or elderly patients. This is a significant breakthrough. It offers a new strategy for these vulnerable populations. The approach could protect their immune systems from self-destruction. This is a stark contrast to existing therapies. Those often focus on reducing viral load or general inflammation.
Learn More:
Are you developing new or improved products, or thinking of applying for a patent? Did you know your research work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? To find out more, please check out our free online eligibility test.
Feel free to book a quick teleconference with one of R&D Tax specialists if you would like to learn more about R&D Tax Credit opportunities.
Who We Are:
Swanson Reed is one of the largest Specialist R&D Tax Credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D Tax Credit consulting services to our clients. We have been exclusively providing R&D Tax Credit claim preparation and audit compliance solutions for over 30 years.
Swanson Reed’s Virginia office provides R&D tax credit consulting and advisory services to Virginia Beach, Norfolk, Chesapeake, Richmond, Newport News, Alexandria, Hampton, Roanoke, Portsmouth, and Suffolk.
Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs. For more information please click here or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
